Quest Diagnostics, Inc. (DGX)
243.87
-0.52
(-0.21%)
USD |
NYSE |
Aug 24, 16:00
243.86
-0.01
(-0.00%)
After-Hours: 20:00
Quest Diagnostics Shareholders Equity (Quarterly) : 7.516B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.516B |
| March 31, 2026 | 7.366B |
| December 31, 2025 | 7.17B |
| September 30, 2025 | 7.258B |
| June 30, 2025 | 7.228B |
| March 31, 2025 | 6.929B |
| December 31, 2024 | 6.778B |
| September 30, 2024 | 6.809B |
| June 30, 2024 | 6.617B |
| March 31, 2024 | 6.432B |
| December 31, 2023 | 6.307B |
| September 30, 2023 | 6.425B |
| June 30, 2023 | 6.249B |
| March 31, 2023 | 6.05B |
| December 31, 2022 | 5.893B |
| September 30, 2022 | 6.235B |
| June 30, 2022 | 6.411B |
| March 31, 2022 | 6.377B |
| December 31, 2021 | 6.444B |
| September 30, 2021 | 6.392B |
| June 30, 2021 | 5.899B |
| March 31, 2021 | 6.745B |
| December 31, 2020 | 6.759B |
| September 30, 2020 | 6.40B |
| June 30, 2020 | 5.831B |
| Date | Value |
|---|---|
| March 31, 2020 | 5.657B |
| December 31, 2019 | 5.641B |
| September 30, 2019 | 5.605B |
| June 30, 2019 | 5.459B |
| March 31, 2019 | 5.29B |
| December 31, 2018 | 5.216B |
| September 30, 2018 | 5.317B |
| June 30, 2018 | 5.223B |
| March 31, 2018 | 5.03B |
| December 31, 2017 | 4.921B |
| September 30, 2017 | 4.794B |
| June 30, 2017 | 4.697B |
| March 31, 2017 | 4.63B |
| December 31, 2016 | 4.628B |
| September 30, 2016 | 4.663B |
| June 30, 2016 | 4.537B |
| March 31, 2016 | 4.636B |
| December 31, 2015 | 4.684B |
| September 30, 2015 | 4.589B |
| June 30, 2015 | 4.314B |
| March 31, 2015 | 4.243B |
| December 31, 2014 | 4.301B |
| September 30, 2014 | 4.182B |
| June 30, 2014 | 4.092B |
| March 31, 2014 | 3.992B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 8.607B |
| DaVita, Inc. | -765.10M |
| OPKO Health, Inc. | 1.184B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 785.73M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.94B |
| Total Liabilities (Quarterly) | 9.04B |
| Debt to Equity Ratio | 0.8493 |
| Current Ratio | 1.591 |
| Net Debt Paydown Yield | 0.16% |